GOTTWALD JOHN D sold $8K of TG (indirect holdings)

GOTTWALD JOHN D sold 1,044 indirectly-held shares of TREDEGAR CORP (TG) at an average of $7.81 ($7.77–$8.00) across 2 trades over 2026-06-02 to 2026-06-03.

Original reporting
SEC EDGAR · GOTTWALD JOHN D
Published Jun 4, 2026, 5:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TG
Bearish
medium confidence
Mentioned
$TG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TGBearishLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock significantly, but may attract short-term traders.

02

Market read

Minor insider sell; limited relevance for most traders.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 3/10Novelty 3/10Timing: post-filing today

Background

SEC Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$TGBearishMedium confidence
Context

Form 4 shows insider Gottwald John D sold ~1,044 shares for $8,157, reducing his stake.

Expected impact

likely modest downward pressure as market prices in the insider sell.

Evidence & confidence

The transaction size is minor relative to float and total market cap, but insider sales often trigger short-term sentiment.

Market effects

No material impact on the broader healthcare sector.

Limited to U.S. investors tracking insider activity.

None

Counterpoint

Given the small size, the sale may be routine and not indicative of future weakness.

Key entities

  • Gottwald John D

    10% owner of Tredegar Corp who sold shares.

  • Tredegar Corp

    U.S.-listed healthcare company (ticker TG).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TGMed

TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS • Net loss from continuing operations of $(2.8) million, or $(0.08) per diluted share, for the third quarter of 2026 compared to net income from continuing operations $7.1 million, or $0.20 per diluted share, for the third quarter of 20

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$TGMed

TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 million, or $0.05 per diluted share, for the second quarte